Indefinite Delivery Contract SPE2DR25D9338

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities and veterans' medical centers nationwide.

The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition strategy, which aims to establish multiple regional prime vendor contracts to increase the DoD's resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The IDC is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across a diverse array of medical product categories.